Eurofins Scientific SE
Eurofins Scientific SE scores highest on Nitro (99) and lowest on Price (36). Its PosiPenta is 62.85 out of 100, better than most similar companies.
Compared with similar companies in the Healthcare sector in Luxembourg.
The five pillars
Details
PPrice
| P/E ratio | 27.41 |
| P/B ratio | 2.97 |
EEarnings
| Trailing EPS | ₹306.64 |
| Forward EPS | ₹494.45 |
NNitro
| Price | 8405.03 |
| 52-week high | 8434.84 |
| 52-week low | 5841.14 |
| Fall from 52-week high | 0.4% |
TTorque
| Return on equity (ROE) | 11.33% |
| Debt-to-equity | 0.96 |
AAnchor
| Beta (price swings) | 0.81 |
| Market cap | ₹1,43,820 Cr |
| Insider holding | 36.55% |
| Dividend yield | 0.92% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Eurofins Scientific SE's PosiPenta score?
Eurofins Scientific SE's PosiPenta is 62.85 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Which PosiPenta pillar is strongest for Eurofins Scientific SE?
Nitro (momentum), with a score of 99 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Eurofins Scientific SE?
Price (valuation), with a score of 36 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.